Silencing the RHBDF2 gene in renal cancer cells leads to down-regulation of the immunosuppressive checkpoint protein PD-L1, even though there is an increase of lymphocyte infiltration into the tumors with high levels of RHBDF2. The gene discussed is RHBDF2; the disease is renal carcinoma.